Sukumar Sakamuri

ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers

Lillian Skidmore, Sukumar Sakamuri, Nick Knudsen et al. · Molecular Cancer Therapeutics · 2020 · 160 citations

Pharmacy, Medicinal Chemistry, Oncology +17

Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells

Juran Kato‐Stankiewicz, Irina Hakimi, Gang Zhi et al. · Proceedings of the National Academy of Sciences · 2002 · 143 citations · Full text

Medicine, Oncology, Pharmacology +15

Total Synthesis of Tubulysin U and V

Alexander Dömlingꝉ, Barbara Beck, Uwe Eichelberger et al. · Angewandte Chemie International Edition · 2006 · 111 citations

Pharmacy, Chemistry, Pharmacology +13

Pharmacophore-Based discovery of substituted pyridines as novel dopamine transporter inhibitors

Istvan Enyedy, Sukumar Sakamuri, Wahiduz A. Zaman et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 87 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of a Novel Dopamine Transporter Inhibitor, 4-Hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-Methylphenyl Ketone, as a Potential Cocaine Antagonist through 3D-Database Pharmacophore Searching. Molecular Modeling, Structure−Activity Relationships, and Behavioral Pharmacological Studies

Shaomeng Wang, Sukumar Sakamuri, Istvan Enyedy et al. · Journal of Medicinal Chemistry · 2000 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17